Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,219 Cr
up ₹41.5 Cr vs Sep 2022
- Stocks held
- 24
- up 1 vs Sep 2022
- Top 10 weight
- 67.9%
- of the portfolio in its ten largest
- Cash & debt
- 1.7%
- cash, money market and debt
- Moves this month
- 2 in · 1 out
- added to 10, trimmed 11
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In October 2022 it disclosed 24 stocks worth ₹1,219 Cr, up ₹41.5 Cr from Sep 2022. Its largest positions were Sun Pharmaceutical Industries Limited (16.6%), Cipla Limited (9.9%), Apollo Hospitals Enterprise Limited (6.9%); the ten largest together made up 67.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 61.4% of its equity. Cash and debt stood at 1.7%. Compared with Sep 2022 the fund entered 2 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
24%
Holds more cash than 24% of peers
What these mean: concentration · cash
Holdings in October 2022
Download CSVEvery line the fund disclosed, with the change against Sep 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 16.63% | up 0.57 pts | ₹203 Cr | up ₹13.6 Cr | Added |
| Cipla Limited | 9.92% | down 0.59 pts | ₹121 Cr | down ₹2.8 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 6.90% | down 0.03 pts | ₹84.1 Cr | up ₹2.5 Cr | Added |
| IPCA Laboratories Limited | 5.86% | down 0.27 pts | ₹71.5 Cr | down ₹78 L | Trimmed |
| Procter & Gamble Health Limited | 5.25% | down 0.28 pts | ₹64 Cr | down ₹1.2 Cr | Trimmed |
| Max Healthcare Institute Limited | 5.14% | down 1.23 pts | ₹62.6 Cr | down ₹12.3 Cr | Trimmed |
| Lupin Limited | 5.13% | down 0.04 pts | ₹62.6 Cr | up ₹1.7 Cr | Added |
| Dr. Reddy's Laboratories Limited | 5.10% | down 0.26 pts | ₹62.1 Cr | down ₹99 L | Trimmed |
| Alkem Laboratories Limited | 4.35% | down 0.33 pts | ₹53 Cr | down ₹2 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 3.65% | down 0.33 pts | ₹44.5 Cr | down ₹2.4 Cr | Trimmed |
| Indoco Remedies Limited | 3.26% | up 0.13 pts | ₹39.8 Cr | up ₹2.9 Cr | Added |
| Intuitive Surgical Inc | 3.12% | up 0.60 pts | ₹38.1 Cr | up ₹8.3 Cr | Added |
| Globus Medical Inc | 3.02% | up 0.16 pts | ₹36.8 Cr | up ₹3.1 Cr | Added |
| Aarti Drugs Limited | 2.81% | up 0.32 pts | ₹34.3 Cr | up ₹4.9 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 2.32% | down 0.04 pts | ₹28.2 Cr | up ₹45 L | Added |
| Abiomed Inc | 2.26% | down 0.11 pts | ₹27.6 Cr | down ₹35 L | Trimmed |
| Abbott Laboratories | 2.12% | down 0.06 pts | ₹25.8 Cr | up ₹16 L | Added |
| Suven Pharmaceuticals Limited | 1.95% | up 1.95 pts | ₹23.8 Cr | up ₹23.8 Cr | New |
| Syngene International Limited | 1.94% | down 0.27 pts | ₹23.7 Cr | down ₹2.3 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.79% | up <0.01 pts | ₹21.8 Cr | up ₹76 L | Added |
| Alembic Pharmaceuticals Limited | 1.72% | up 0.33 pts | ₹21 Cr | up ₹4.6 Cr | Added |
| Cash, TREPS & receivables | 1.68% | up 0.33 pts | ₹20.5 Cr | up ₹4.6 Cr | Added |
| Illumina Inc | 1.29% | up 0.17 pts | ₹15.8 Cr | up ₹2.6 Cr | Added |
| Kovai Medical Center and Hospital Limited | 1.28% | down 0.06 pts | ₹15.6 Cr | down ₹14 L | Trimmed |
| MedPlus Health Services Limited | 0.93% | down 0.07 pts | ₹11.4 Cr | down ₹49 L | Trimmed |
| Pfizer Limited | 0.55% | up 0.55 pts | ₹6.7 Cr | up ₹6.7 Cr | New |
What changed, Sep 2022 to Oct 2022
New New positions (2)
- Suven Pharmaceuticals Limited1.9% · ₹23.8 Cr
- Pfizer Limited0.5% · ₹6.7 Cr
Exited Exited (1)
- Unichem Laboratories Limitedwas 1.1% · ₹13.4 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹13.6 Cr (+0.57% pts)
- Intuitive Surgical Incup ₹8.3 Cr (+0.60% pts)
- Aarti Drugs Limited ₹4.9 Cr (+0.32% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2022, the weight rose most in Pharmaceuticals & Biotechnology (+2.2 pts) and Healthcare Equipment & Supplies (+0.8 pts), and fell most in Healthcare Services (−1.8 pts) and Pharmaceuticals (−1.1 pts).
- Pharmaceuticals & Biotechnology59.2% → 61.4%+2.2 pts
- Healthcare Equipment & Supplies5.6% → 6.4%+0.8 pts
- Healthcare Services25.1% → 23.3%−1.8 pts
- Pharmaceuticals6.7% → 5.6%−1.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2019 | Oct 2021 | Apr 2022 | Jul 2022 | Sep 2022 | Oct 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.5% | 58.7% | 55.4% | 57.0% | 59.2% | 61.4% |
| Healthcare Services | 18.9% | 25.4% | 28.0% | 26.0% | 25.1% | 23.3% |
| Healthcare Equipment & Supplies | — | 6.3% | 5.5% | 5.6% | 5.6% | 6.4% |
| Pharmaceuticals | 11.0% | 7.0% | 7.1% | 7.7% | 6.7% | 5.6% |
| Insurance | 1.6% | 2.5% | 2.5% | 2.5% | 2.4% | 2.4% |
| Retailing | — | — | 1.5% | 1.2% | 1.0% | 1.0% |
Allocation in Oct 2022change vs Sep 2022
- Pharmaceuticals & Biotechnology (11)61.4%▲ 2.2 pts
- Healthcare Services (7)23.3%▼ 1.8 pts
- Healthcare Equipment & Supplies (2)6.4%▲ 0.8 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Oct 2022
1.7%
▲ 0.3 pts vs Sep 2022
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- −0.3%
- Oct 2021 · now ▲ 2.0 pts
- Last 12 months
- −0.1% – 3.7%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.